NO20054015D0 - Hurtige absorpsjons selektive 5-HT agonist formuleringer. - Google Patents

Hurtige absorpsjons selektive 5-HT agonist formuleringer.

Info

Publication number
NO20054015D0
NO20054015D0 NO20054015A NO20054015A NO20054015D0 NO 20054015 D0 NO20054015 D0 NO 20054015D0 NO 20054015 A NO20054015 A NO 20054015A NO 20054015 A NO20054015 A NO 20054015A NO 20054015 D0 NO20054015 D0 NO 20054015D0
Authority
NO
Norway
Prior art keywords
rapid absorption
agonist formulations
absorption selective
selective
agonist
Prior art date
Application number
NO20054015A
Other languages
English (en)
Other versions
NO20054015L (no
Inventor
Paul J Maes
Naima Mezaache
Djelila Mezaache
Steve Frisbee
Original Assignee
Biovail Lab Int Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovail Lab Int Srl filed Critical Biovail Lab Int Srl
Publication of NO20054015D0 publication Critical patent/NO20054015D0/no
Publication of NO20054015L publication Critical patent/NO20054015L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20054015A 2003-02-19 2005-08-30 Hurtige absorpsjons selektive 5-HT agonist formuleringer. NO20054015L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44774103P 2003-02-19 2003-02-19
PCT/US2004/004572 WO2004073632A2 (en) 2003-02-19 2004-02-18 Rapid absorption selective 5-ht agonist formulations

Publications (2)

Publication Number Publication Date
NO20054015D0 true NO20054015D0 (no) 2005-08-30
NO20054015L NO20054015L (no) 2005-09-16

Family

ID=32908492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054015A NO20054015L (no) 2003-02-19 2005-08-30 Hurtige absorpsjons selektive 5-HT agonist formuleringer.

Country Status (8)

Country Link
US (1) US20040162333A1 (no)
EP (1) EP1594470A4 (no)
JP (1) JP2006523620A (no)
AU (1) AU2004212976A1 (no)
CA (1) CA2514875A1 (no)
MX (1) MXPA05008838A (no)
NO (1) NO20054015L (no)
WO (1) WO2004073632A2 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05010070A (es) * 2003-04-11 2005-11-23 Pfizer Combinacion farmaceutica.
JP5183068B2 (ja) * 2003-12-22 2013-04-17 フィンレイ，ウォーレン，エイチ 大気噴出凍結乾燥法による粉末形成
US20070269510A1 (en) * 2004-09-29 2007-11-22 Sudarshan Nimbalkar Solid Unit Dosage Forms of 5-Ht1 Agonist
GB0501809D0 (en) * 2005-01-28 2005-03-09 Pharmakodex Ltd Anti-migraine formulations
EP1938842A4 (en) * 2005-09-01 2013-01-09 Eisai R&D Man Co Ltd METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION COMPRISING IMPROVED CRASHING CHARACTERISTICS
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US20090136570A1 (en) * 2006-01-20 2009-05-28 Bhagwant Rege Taste-Masked Tablets and Granules
JP2009527504A (ja) * 2006-02-23 2009-07-30 イオメディックス スリープ インターナショナル エスアールエル 良質な睡眠の誘導および維持のための組成物および方法
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
WO2008081774A1 (ja) * 2006-12-26 2008-07-10 Shionogi & Co., Ltd. リスペリドンを含有する口腔内崩壊錠剤および苦味抑制製剤
JP5537927B2 (ja) 2007-03-13 2014-07-02 大日本住友製薬株式会社 口腔内崩壊錠
ES2729925T3 (es) 2007-11-13 2019-11-07 Meritage Pharma Inc Composiciones de corticosteroides
EP2756756B1 (en) * 2008-04-28 2016-01-06 Zogenix, Inc. Novel formulations for treatment of migraine
CA2728436C (en) * 2008-06-20 2016-07-26 Merck Patent Gmbh Directly compressible and rapidly disintegrating tablet matrix
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
ES2467141T3 (es) * 2009-07-10 2014-06-12 Merck Patent Gmbh Composición para la fabricación de comprimidos y procedimiento para su preparación
WO2011003602A2 (de) * 2009-07-10 2011-01-13 Merck Patent Gmbh Wasserarmes tablettierhilfsmittel und verfahren zu seiner herstellung
US8906949B2 (en) 2010-05-21 2014-12-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of zolmitriptan and process for preparing the same
US8901159B2 (en) 2010-07-01 2014-12-02 Allergan, Inc. Inhibition of inflammation by simultaneous blockade of multiple prostanoid receptors
RU2580609C2 (ru) 2011-04-18 2016-04-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Противоопухолевое терапевтическое средство
EP3444363B1 (en) 2011-06-03 2020-11-25 Eisai R&D Management Co., Ltd. Biomarkers for prediciting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
AR089857A1 (es) * 2012-02-02 2014-09-24 Glaxosmithkline Llc Comprimido antiacido para refrescar el aliento
KR20150098605A (ko) 2012-12-21 2015-08-28 에자이 알앤드디 매니지먼트 가부시키가이샤 퀴놀린 유도체의 비정질 형태 및 그의 제조방법
SG11201509278XA (en) 2013-05-14 2015-12-30 Eisai R&D Man Co Ltd Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
SI3524595T1 (sl) 2014-08-28 2022-10-28 Eisai R&D Management Co., Ltd. Derivat kinolina visoke čistosti in postopek njegove proizvodnje
WO2016136745A1 (ja) 2015-02-25 2016-09-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 キノリン誘導体の苦味抑制方法
KR102662228B1 (ko) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
CA2988707C (en) 2015-06-16 2023-10-10 Eisai R&D Management Co., Ltd. Combination of cbp/catenin inhibitor and immune checkpoint inhibitor for treating cancer
EP3316865A4 (en) 2015-07-02 2019-01-23 Civitas Therapeutics, Inc. POWDERS CONTAINING TRIPTAN, FOR PULMONARY DELIVERY

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077822A (en) * 1993-09-14 2000-06-20 Dumex-Alpharma A/S Drug salts
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
ES2199981T3 (es) * 1994-02-16 2004-03-01 Abbott Laboratories Modo de preparacion de formulaciones farmaceuticas de particulas finas.
US5849322A (en) * 1995-10-23 1998-12-15 Theratech, Inc. Compositions and methods for buccal delivery of pharmaceutical agents
PT966464E (pt) * 1997-03-03 2003-09-30 Basilea Pharmaceutica Ag 2,4-diaminopirimidinas substituidas
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
DE69811233T2 (de) * 1997-10-27 2003-11-20 Merck Patent Gmbh Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
US6117452A (en) * 1998-08-12 2000-09-12 Fuisz Technologies Ltd. Fatty ester combinations
JP2004525854A (ja) * 1999-06-02 2004-08-26 ヘキサル・アクチェンゲゼルシャフト 水中に不溶性及び／又は難溶性である活性物質の鼻腔内投与用薬剤組成物
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU2001279284A1 (en) * 2000-07-05 2002-01-14 Capricorn Pharma, Inc Rapid-melt semi-solid compositions, methods of making same and methods of using same
JP2002037745A (ja) * 2000-07-25 2002-02-06 ▲高▼田 ▲寛▼治 水溶性の難・低吸収性薬物のバイオアベイラビリティ改善技術
JP4092203B2 (ja) * 2000-12-21 2008-05-28 ニトロメッド，インク． 新規のシクロオキシゲナーゼ２選択的阻害剤としての置換アリール化合物、組成物、および使用方法
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque

Also Published As

Publication number Publication date
WO2004073632A3 (en) 2004-11-18
US20040162333A1 (en) 2004-08-19
EP1594470A2 (en) 2005-11-16
NO20054015L (no) 2005-09-16
JP2006523620A (ja) 2006-10-19
CA2514875A1 (en) 2004-09-02
WO2004073632A2 (en) 2004-09-02
MXPA05008838A (es) 2006-02-17
EP1594470A4 (en) 2007-10-17
AU2004212976A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
NO20054015D0 (no) Hurtige absorpsjons selektive 5-HT agonist formuleringer.
NO20041144L (no) Gassloftingsventil.
NO20032883L (no) Bolgekraftverk.
NO20053312D0 (no) Benzofuranderivat.
FI20030261A0 (fi) Iskulaite
NL1024983A1 (nl) Morfolinen als dopamineagonisten.
FR2855029B1 (fr) Cache-pot.
NO20040394L (no) Fullpumpesentreringsstotte.
ITBO20030521A1 (it) Endoscopio per uso oculistico.
ITMI20031078A1 (it) Copridivano.
ITGE20030068A1 (it) Termoalgometro.
ES1055830Y (es) Mosquitera.
ITMO20030041A1 (it) Mezzi decoratori tubolari.
ES1055694Y (es) Dispositivo de abatimiento para respaldos de butacas.
ES1056273Y (es) Apoyabrazos para asiento.
ITMO20030005A0 (it) Apparato orientatore.
ES1055853Y (es) Almohadon piramidal reposapies.
ES1055979Y (es) Dispositivo sujeta-pales.
ES1055896Y (es) Dispositivo antivibrador.
BR8203223Y1 (pt) manete ajustável.
ITBS20030095A1 (it) Maniglia.
ITCN20030005A1 (it) Dispositivo anti-turbolenza.
ES1056476Y (es) Columpio.
FIU20030297U0 (fi) Käsisaha
ITFE20030010A1 (it) Atomizzatore per barbatelle.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application